[PDF] Top 20 Entre policía y administración. El derecho administrativo y su enseñanza en España
Has 10000 "Entre policía y administración. El derecho administrativo y su enseñanza en España" found on our website. Below are the top 20 most common "Entre policía y administración. El derecho administrativo y su enseñanza en España".
Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment
... VTE treatment, the DOACs are non-inferior to well- managed VKA therapy ...in patients receiving DOACs with lower risks of intracranial bleeding (63% relative reduction), fa- tal bleeding (64% relative ... See full document
5
Direct oral anticoagulants and venous thromboembolism
... these challenges, a new class of anticoagulant drugs has been developed with the aim of being at least as efficacious but with a more practical profile ...(i.e. oral administration and no laboratory ... See full document
8
<p>Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study</p>
... Direct oral anticoagulants (DOAC) such as dabigatran, rivaroxaban, apixaban and edoxaban have been developed to overcome the challenges of using ...a direct inhibitor of Factor IIa, ... See full document
24
Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
... fibrillation patients who have failed Or are unsuitablE for vitamin K antagoniSt treatment; bid, twice daily; CrCl, creatinine clearance; ENGAGE AF-TIMI 48, Effective Anticoagulation With Factor Xa Next ... See full document
15
Point of care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
... POCT designed for VKA monitoring [2]. However, CoaguChek® lacked sensitivity to apixaban and dabigatran. Hemochron® Signature (ITC, Edison, NJ, USA) is another coagulation POCT that uses a different PT/INR assay to ... See full document
8
Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
... The meta-analysis on which these margins are based included a large variety of studies undertaken over a long time period (i.e. between 1960 and 2013). Our search yielded more than 5000 potential references for review. ... See full document
12
Evaluation of bleeding in patients receiving direct oral anticoagulants
... Over the past 7 years since the approval of the first DOAC, data from Phase III clinical trials has been scrutinized to bet- ter understand and apply both safety and efficacy results to clinical practice. Table 1 ... See full document
51
Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence
... The advantage that DOACs provide over other OACs is their predictable pharmacokinetic (PK) and pharmaco- dynamic (PD) profiles in healthy patients. As such, there is less monitoring required for determination of ... See full document
12
Laboratory Tests in Assessing the Bleeding Risk in Patients Receiving Direct Oral Anticoagulants (DOACs)
... Direct oral anticoagulants (DOACs)—apixaban, rivaroxaban and dabigatran have become the first line medications for patients with ...these patients. This study compared laboratory test ... See full document
19
Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment
... limited their meta-analysis results to findings favoring extended-duration prophylaxis with DOACs. Our analysis adds the critical findings that, compared with short-duration enoxaparin prophylaxis, thromboprophylaxis ... See full document
8
Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention
... DOAC, direct oral anticoagulant; GI, gastrointestinal; HIV, human immunodeficiency virus; ICH, intracranial hemorrhage; NA, not applicable; NSAID, nonsteroidal anti-inflammatory drug; od, once daily; P-gp, ... See full document
11
Utilization and prescribing patterns of direct oral anticoagulants
... or incomplete documentation. This limitation was mitigated by verifying data with multiple sources, such as reviewing both outpatient and inpatient records for documentation of an AE. Finally, investigators noted that a ... See full document
9
Bleeding complications from the direct oral anticoagulants
... 26 patients, 14 were on a reduced dose of dabigatran (110 mg) or rivaroxaban (15 ...those patients were either of older age or had impaired renal ... See full document
6
New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
... stroke. Oral anticoagulation therapy has been shown to decrease the incidence of cardioembolic stroke in patients with AF by more than ...induce patients’ dissatisfaction reduce quality of patient ... See full document
10
<p>When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics</p>
... 1329 patients with AF, a major GI-bleeding, and an interruption of warfarin for 48 hrs were ...197 patients hospitalized for GI-bleeding, it was observed that warfarin resumption after a median of 5 days ... See full document
83
Use of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity?
... with AF do not experience any symptoms, some patients can experience heart palpitations, lack of energy, dizziness, or shortness of breath. Additionally, AF can lead to an increase in the risk of stroke by ... See full document
41
Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
... in patients treated with dabigatran) or nonspecific reversal agents, such as PCC (50 IU/kg followed by 25 IU/kg, if required) or activated prothrombin complex concentrate (aPCC; 50 IU/kg), may be considered ... See full document
12
Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin
... New Oral Anticoagulants 33 showed that DOAC-associated ICHs were associated with higher mortality rates, more un- favorable outcomes, and greater hematoma expansion fre- ...in patients with ... See full document
29
Epilepsy in patients with autism: links, risks and treatment challenges
... study design was unusual. They examined follow-up data for 85,201 individuals with epilepsy, 80,511 siblings of these individuals and 98,534 offspring. In addition, those with epilepsy were compared with five controls, ... See full document
16
<p>Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients</p>
... in patients with ...cancer patients with VTE have higher rates of both VTE recurrence and ...of treatment for cancer-associated VTE for over a decade, direct oral anticoagulants ... See full document
21
Related subjects